Drugs / Yishen Daluo Yin Granule
Yishen Daluo Yin Granule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07029867 | Mar → Oct 2026 expected | relapsing-remitting multiple sclerosis | Ying Gao | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yishen Daluo Yin Granule | “Efficacy and Safety of Traditional Chinese Mecicine Yishen Daluo Yin Granule for Relapsing-remitting Multiple Sclerosis: A Randomized Controlled Trial” NCT07029867 ↗ |
| Known as | Yishen Daluo Yin granuls | “Yishen Daluo Yin granuls” NCT07029867 ↗ |
| Known as | YSDLY | “The aim of this study is to evaluate the efficacy and safety of YSDLY granule in patients with RRMS.” NCT07029867 ↗ |